Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Orthocell Ltd ( (AU:OCC) ) is now available.
Orthocell Limited has released its corporate governance statement for the financial year ending June 30, 2025, confirming adherence to the ASX Corporate Governance Council’s principles and recommendations. This announcement underscores Orthocell’s commitment to transparency and accountability, which may strengthen its reputation among investors and stakeholders, potentially impacting its market positioning positively.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Limited operates in the biotechnology industry, focusing on regenerative medicine. The company specializes in developing products for the repair of soft tissue injuries and musculoskeletal conditions, aiming to enhance the quality of life for patients.
Average Trading Volume: 617,569
Technical Sentiment Signal: Buy
Current Market Cap: A$293.8M
For detailed information about OCC stock, go to TipRanks’ Stock Analysis page.